Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
434.47
431.23
3,083.12
473.98
330.89
308.86
254.16
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
434.47
431.23
3,083.12
473.98
330.89
308.86
254.16
Raw Material Cost
103.18
100.58
86.71
79.16
125.34
84.05
87.25
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.29
0.28
0.28
Selling and Distribution Expenses
44.55
71.29
83.38
70.05
68.92
63.03
69.08
Other Expenses
14.29
7.71
12.69
10.72
10.12
7.09
9.04
Total Expenditure (Excl Depreciation)
290.62
248.94
296.95
256.41
295.73
218.26
247.03
Operating Profit (PBDIT) excl Other Income
143.8
182.3
2786.2
217.60000000000002
35.2
90.60000000000001
7.1
Other Income
-17.85
-9.16
9.57
13.12
32.14
16.81
23.54
Operating Profit (PBDIT)
158.66
203.33
2,826.00
255.20
95.95
138.88
59.44
Interest
0.00
0.00
0.00
0.00
0.29
0.28
0.28
Exceptional Items
26.02
23.67
18.46
9.54
13.40
9.15
19.52
Gross Profit (PBDT)
331.29
330.65
2,996.41
394.82
205.55
224.81
166.91
Depreciation
35.56
35.56
30.88
30.88
31.03
31.03
31.48
Profit Before Tax
149.12
191.44
2,813.57
233.85
78.03
116.72
47.19
Tax
4.25
17.72
402.89
23.33
-9.51
9.97
-5.75
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
193.21
178.12
2,500.44
208.54
87.37
102.96
471.53
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
193.21
178.12
2,500.44
208.54
87.37
102.96
471.53
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-1.69
-1.56
1.70
-4.59
-1.73
-2.84
-2.89
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
191.52
176.56
2,502.15
203.95
85.64
100.12
468.64
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
8,503.91
8,620.06
8,452.97
5,898.69
5,698.91
5,671.32
5,567.64
Earnings per share (EPS)
0.22
0.2
2.79
0.23
0.1
0.12
0.53
Diluted Earnings per share
0.22
0.2
2.79
0.23
0.1
0.12
0.53
Operating Profit Margin (Excl OI)
32.44%
41.03%
90.35%
44.56%
9.91%
29.47%
1.73%
Gross Profit Margin
42.51%
52.64%
92.26%
55.85%
32.96%
47.84%
30.95%
PAT Margin
44.47%
41.3%
81.1%
44.0%
26.4%
33.33%
185.52%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 31.31% vs 1.10% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 123.71% vs 140.45% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 176.65% vs -7.80% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is -100.00% vs 0.00% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
434.47
0
434.47
Other Operating Income
0.00
0.00
0.00
Total Operating income
434.47
0
434.47
Raw Material Cost
103.18
0
103.18
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
44.55
0
44.55
Other Expenses
14.29
0.00
14.29
Total Expenditure (Excl Depreciation)
290.62
0
290.62
Operating Profit (PBDIT) excl Other Income
143.85
0.00
143.85
Other Income
-17.85
0
-17.85
Operating Profit (PBDIT)
158.66
0
158.66
Interest
0.00
0
0.00
Exceptional Items
26.02
0
26.02
Gross Profit (PBDT)
331.29
0
331.29
Depreciation
35.56
0
35.56
Profit Before Tax
149.12
0
149.12
Tax
4.25
0
4.25
Provisions and contingencies
0
0
0.00
Profit After Tax
193.21
0
193.21
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
193.21
0
193.21
Share in Profit of Associates
0
0
0.00
Minority Interest
-1.69
0
-1.69
Other related items
0.00
0.00
0.00
Consolidated Net Profit
191.52
0
191.52
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
8,503.91
0
8,503.91
Earnings per share (EPS)
0.22
0
0.22
Diluted Earnings per share
0.22
0
0.22
Operating Profit Margin (Excl OI)
32.44%
0%
0.00
32.44%
Gross Profit Margin
42.51%
0%
0.00
42.51%
PAT Margin
44.47%
0%
0.00
44.47%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 43.45 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 0.77% vs -86.01% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 31.31% vs 1.10% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 19.15 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 8.44% vs -92.94% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 123.71% vs 140.45% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 17.65 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -16.94% vs -92.45% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 176.65% vs -7.80% in Jun 2025
Quarterly - Interest
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 32.44%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
